Moleculin Biotech announces 1-for-20 reverse stock split effective October 20
MBRX•Moleculin Biotech will implement a 1-for-20 reverse stock split effective October 20, 2026. Outstanding common shares will fall from approximately 20.9 million to 1.05 million, while authorized common shares remain at 500 million.
1. Split details
The split takes effect at 12:01 a.m. Eastern Time on October 20, 2026, and shares will begin trading on a split-adjusted basis on Nasdaq that day under the existing ticker MBRX. Fractional shares will be paid in cash rather than issued.
